+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 18Years - 45Years
All Genders
Healthy Volunteers
ID07905105

Randomized, Double-blind Study to Evaluate Safety and Tolerability of Single-Dose CYT-1010 in Healthy Adults and Patients With Acute Pain After Third Molar Extraction

Led by Cytogel Pharma, LLC · Updated on 2026-10-29

32

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the safety and tolerability of single, increasing doses of the drug CYT-1010 in both healthy adults and individuals experiencing moderate to severe pain after removal of third molars wisdom teeth. This randomized, double-blind trial compares different doses of CYT-1010 with placebo to understand its effects on acute postoperative dental pain and overall participant safety. Participants receive a single intravenous dose of either 5 mg or 10 mg CYT-1010 or a matching placebo. The study includes separate cohorts of healthy volunteers and dental pain patients, each receiving the drug or placebo accordingly. After dosing, participants are monitored closely over a period extending up to seven days to assess pain relief and any treatment-emergent adverse events. During the trial, participants undergo various evaluations including blood tests, vital signs, pain assessments using standard scales, and monitoring of sedation and respiratory parameters. Healthy volunteers remain confined to the clinical unit for about 1.5 days with follow-up visits for safety checks. The main outcomes measured include the number of participants experiencing adverse events and the sum of pain intensity differences over two hours for dental pain patients. The study aims to complete by October 2027.

CONDITIONS

Brief Title

A Study of CYT-1010 in Healthy Volunteers and Participants With Acute Pain After Third Molar Extraction

Research Team

J

Jenny Hunt

M

Mike McCarthy

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here